Stryker's q guidance system for cranial applications receives fda clearance

Kalamazoo, mich.--(business wire)--stryker (nyse:syk), one of the world's leading medical technology companies, today announced that its q guidance system with cranial guidance software received 510(k) clearance from the u.s. food and drug administration. the q guidance system is an image-based planning and intraoperative guidance system designed to support cranial surgeries. recently launched in september 2022, the q guidance system for spinal applications is currently available on the market.
SYK Ratings Summary
SYK Quant Ranking